Significant Ownership of Flagship Ventures Fund V, L.P.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Flagship Ventures Fund V, L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Noubar B. Afeyan, Ph.D. - Noubar B. Afeyan, Ph.D., Manager of General Partner
- Manager location
- Cambridge, MA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Flagship Ventures Fund V, L.P. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Flagship Ventures Fund V, L.P.
Significant Ownership of Flagship Ventures Fund V, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OMGAQ | OMEGA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 53% | $1,461,279 | 29,225,579 | Noubar Afeyan | 29 Dec 2024 | ||
| FHTX | FOGHORN THERAPEUTICS INC. | Common Stock, $0.0001 par value per share | 27% | $112,194,766 | 20,774,885 | Noubar Afeyan | 09 Jan 2026 |
Schedules 13D/G Reported by Flagship Ventures Fund V, L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.